Ralexar Therapeutics
0 followers
Ralexar Therapeutics company is developing topical and systemic therapies based on the Liver X Receptor (LXR) modulators. The initial focus for the company is on the clinical development of ALX-101, a topical LXR-based therapy, for the treatment of various cutaneous inflammatory disorders, including... Read more
Org chart
Dave Pfeiffer
Chief Executive Officer
Dave Pfeiffer
Collapse
No reports!
